Glutathione 1500mg
- Createtime: 2026-06-10
- Updatetime: 2026-06-01
Product Details
| useage |
For laboratory research use only, applicable to studies on antioxidant mechanisms, oxidati
|
| deliveryInfo |
|
| appearance |
White lyophilized powder
|
| aliasen |
|
| supplyCapacity |
100G/Day
|
| harbor |
Hong Kong
|
| minorder |
1G
|
| Payment method |
Alibaba, PayPal, USDT, bank card, Western Union remittance
|
| Delivery date |
7 days
|
| Whatsapp |
86 131 7158 8872
|
Name: Glutathione
Synonyms: gsh; 1r4w; 1oe8; 1oe7; 1lbk; Ledac; G0074; s4606; Copren; D00014; P19615; G-3980; C00051; C02471; 70-18-8; Glutham; Tathion; Q116907; TAD 600; MSK8304; FG61468; DB00143; F213215; CS-7948; glutide; FG10640; Panaron; Triptide; HY-D0187; Tathione; ST097777; Isethion; Glutinal; SY012937; Atomolan; GTPL6737; DS-14675; Neuthion; NSC758199; ReadiSorb; HMS500D17; EBC-02054; CCG-38876; glutatiol; NSC400639; 200-725-4; NSC-758199; NSC-400639; CHEMBL1543; bmse000956; bmse000952; 95687-20-0; Agifutol S; NSC 400639; bmse000185; glutatione; GLXC-21963; HMS1921N22; Glutathion; Glutathiol; GAN16C9B8O; CCRIS 2094; SMP1_000247; Deltathione; CAS-70-18-8; IDI1_000075; 106272-20-2; SCHEMBL9167; Bakezyme RX; CHEBI:16856; Z2183947556; C10H17N3O6S; MFCD00065939; KBio2_000899; DTXCID903101; NINDS_000075; l-glutatione; MLS001333069; KBio2_003467; KBio3_002012; BDBM50422268; KBio1_000075; Glu(Cys-Gly); Tathion (TN); SMR000857220; SPBio_001519; Tox21_111371; KBio2_006035; EN300-311690; RefChem:5864; KBioGR_001352; glutathionate; DTXSID6023101; L-Glutathione; KBioSS_000899; AB00443568_03; DivK1c_000075; AKOS015999135; Glutathione-SH; Tox21_111371_1; SR-05000002567; SCHEMBL1384624; Glutathione 2%; Glutathione SH; Glutathione CRS; NCGC00264046-02; Aec glutathione; SPECTRUM1502248; Glutathione/GSH; NCGC00094976-01; glutathione red; GLUTATHIONE, L-; UNII-GAN16C9B8O; Spectrum_000419; Spectrum4_001056; Spectrum2_001500; GLUTATHIONE [II]; [Glu(-Cys)]n-Gly; Spectrum5_000940; red. glutathione; Spectrum3_000946; GLUTATHIONE [MI]; EINECS 200-725-4; MeSH ID: D005978; SR-05000002567-1; SR-05000002567-2; SBI-0051743.P002; gamma-Glu-Cys-Gly; C(N-.gamma.Glu-)G; Glutathione [JAN]; Glutathione (JP18); GLUTATHIONE [VANDF]; GLUTATHIONE [MART.]; Glutathione reduced; Brain Rhabilitation; Reduced glutathione; GLUTATHIONE [USP-RS]; L-Glutathione reduce; GLUTATHIONE [WHO-DD]; Glutathione, Reduced; Brain Rehabilitation; gamma L Glu L Cys Gly; Glutathione (reduced); Glutathione [BAN:JAN]; L-Glutathione Reduced; SDCCGMLS-0066687.P001; Reduced l-glutathione; gamma-L-Glu-L-Cys-Gly; L-Glutathione, reduced; Cys(N-.gamma.Glu-)-Gly; Pharmakon1600-01502248; BRD-K69346723-001-04-8; Knuckle WhiteningLotion; Glutathione reduced form; Knuckle Whitening Lotion; Pharm Biol 11: 539 (1968); Glutathione, Reduced Form; High Thione Extract YH 15; COLLAGEN XTRA WHITE SERUM; K2LTS Brain Rhabilitation; ?-Glutamylcysteinylglycine; Glutathione (Reduced type); K2LTS Brain Rehabilitation; GLUTATHIONE [EP MONOGRAPH]; -Glutamylcysteinylglycine; L-Glutathione reduced form; L-Glutathione (reduced form); Γ-glutamyl-cysteinyl-glycine; HARUTO HANGOVER DEFENCEPATCH; Certified Reference Material; L-Glutathione reduced, 97.0%; L-Glutathione, reduced (GSH); L-glutamyl-L-cysteinylglycine; L-Γ-Glutamyl-L-cysteiylglycin; gamma-Glutamylcysteinylglycine; L-Glutathione reduced, >=98.0%; -L-Glutamyl-L-cysteinylglycine; 5-l-glutamyl-l-cysteinylglycine; L-Γ-Glutamyl-L-cysteinylglycine; ?-L-Glutamyl-L-cysteinylglycine; L-?-glutamyl-L-cysteinylglycine; GZE Glutathione BrighteningSoap; L--Glutamyl-L-cysteinylglycine; gamma-glutamyl-cysteinyl-glycine; Glutathione Reduced(GSH Reduced); ?-L-Glutamyl-L-Cysteinyl-Glycine; L-g-glutamyl-L-cysteinyl-glycine; L-|_-Glutamyl-L-cysteinylglycine; Γ-L-Glutamyl-L-cysteinyl-glycine; gamma-L-Glutamylcysteinylglycine; (gamma-Glutamylcysteine)n-glycine; Glycine, L-Γ-glutamyl-L-cysteinyl-; Glycine,L--glutamyl-L-cysteinyl-; gamma-l-glutamyl-l-cysteinylglycine; gamma L Glutamyl L Cysteinylglycine; l-gamma-Glutamyl-l-cysteinylglycine; gamma-L-Glutamyl-L-cysteinyl-glycine; L-gamma-glutamyl-L-cysteinyl-glycine; N-(N-L-?-Glutamyl-L-cysteinyl)glycine; N-(N-L--Glutamyl-L-cysteinyl)glycine; N-(N-L-g-Glutamyl-L-cysteinyl)glycine; .gamma.-L-Glutamyl-L-cysteinyl-glycine; Glycine, L-gamma-glutamyl-L-cysteinyl-; L-Glutathione reduced, BioXtra, >=98.0%; Glycine, L-.gamma.-glutamyl-L-cysteinyl-; Glycine,N-(N-L--glutamyl-L-cysteinyl)-; N-(N-L-gamma-Glutamyl-L-cysteinyl)glycine; Glycine, N- (N-L-Γ-glutamyl-L-cysteinyl)-; n-(n-l-gamma-glutamyl-l-cysteinyl)-glycin; N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine; L-Glutathione, reduced, tested to USP spec; N(N-L-.gamma.-Glutamyl-L-cysteinyl)glycine; BenzenaMine, 2-[(4-Methoxyphenyl)Methoxy]-; N-(N-L-.gamma.-Glutamyl-L-cysteinyl)glycine; Glycine, N-(N-L-gamma-glutamyl-L-cysteinyl); glycine, N-(N-L-gamma-glutamyl-L-cysteinyl)-; Glutathione, Pharmaceutical Secondary Standard; Glutathione 100 microg/mL in Acetonitrile:Water; L-Glutathione reduced, Vetec(TM) reagent grade, >=98%; Glutathione, European Pharmacopoeia (EP) Reference Standard; Glutathione, United States Pharmacopeia (USP) Reference Standard; L-Glutathione reduced, cell culture tested, BioReagent, >=98.0%, powder; N5-((R)-1-((Carboxymethyl)amino)-3-mercapto-1-oxopropan-2-yl)-L-glutamine; (2S)-2-Amino-4-(1-(carboxymethyl)carbamoyl-(2R)-2-sulfanylethylcarbamoyl)butanoic acid; (2S)-2-amino-4-{[(1R)-1-[(carboxymethyl)carbamoyl]-2-sulfanylethyl]carbamoyl}butanoic acid; (2S)-2-amino-4-(((1R)-1-((carboxymethyl)carbamoyl)-2-sulfanylethyl)carbamoyl)butanoic acid; 4-(N-{(1R)-1-[N-(carboxymethyl)carbamoyl]-2-sulfanylethyl}carbamoyl)(2S)-2-ami nobutanoic acid; (S)-2-Amino-5-((R)-1-(carboxymethylamino)-3-mercapto-1-oxopropan-2-ylamino)-5-oxopentanoic acid; (2S)-2-amino-5-(((2R)-1-(carboxymethylamino)-1-oxo-3-sulfanylpropan-2-yl)amino)-5-oxopentanoic acid; (2S)-2-azaniumyl-5-(((2R)-1-(carboxymethylamino)-1-oxo-3-sulfanylpropan-2-yl)amino)-5-oxopentanoate; (2S)-2-amino-5-[[(2R)-1-(carboxymethylamino)-1-oxo-3-sulfanylpropan-2-yl]amino]-5-oxopentanoic acid; (S)-2-Amino-5-(((R)-1-((carboxymethyl)amino)-3-mercapto-1-oxopropan-2-yl)amino)-5-oxopentanoic acid; (2S)-2-Amino-5-({(2R)-1-[(carboxymethyl)amino]-1-oxo-3-sulfanyl-2-propanyl}amino)-5-oxopentanoic acid; (5Z)-5-({(1Z,2R)-1-[(Carboxymethyl)imino]-1-hydroxy-3-sulfanyl-2-propanyl}imino)-5-hydroxy-L-norvaline; (2S)-2-amino-5-[[(1R)-2-(carboxymethylamino)-2-oxo-1-(sulfanylmethyl)ethyl]amino]-5-oxo-pentanoic acid; L-Norvaline, 5-[[(1R,2Z)-2-[(carboxymethyl)imino]-2-hydroxy-1-(mercaptomethyl)ethyl]imino]-5-hydroxy-, (5Z)-; (2S)-2-amino-5-[[(2R)-1-(carboxymethylamino)-1-oxo-3-sulfanylpropan-2-
yl]amino]-5-oxopentanoic acid
CAS Registry number: 70-18-8
EINECS:200-725-4
Molecular Formula: C10H17N3O6S
Boiling Point: 410.1 ℃
Flash Point: 754.5 ℃ at 760 mmHg
Refractive index: 1.571
Density: 1.441
Appearance: White Powder
Safety Statements: S24/25
Transport:NONH for all modes of transport